MIOSTAT .1 mg/mL

Carbachol, the active ingredient in MIOSTAT, is a muscarinic agonist presented as a 0.1 mg/mL solution for ophthalmic use. It is used to induce miosis during intraocular surgery and to manage certain eye conditions. GNH USA supplies MIOSTAT as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals and clinics worldwide.

MIOSTAT is a sterile balanced salt solution of carbachol, designed for intraocular injection. It is distributed by Alcon Laboratories, Inc., and is used in specific ophthalmic procedures to achieve the desired therapeutic effects.

MIOSTAT is a cholinergic agent used in ophthalmic procedures. It is primarily indicated for the following conditions:

- Intraocular surgery: Induces miosis to facilitate surgical procedures. - Glaucoma: Reduces intraocular pressure by increasing the outflow of aqueous humor. - Postoperative ocular hypotony: Helps manage intraocular pressure elevation following cataract surgery.

MIOSTAT may cause various side effects, ranging from common to serious. Common side effects include:

Common Side Effects: - Headache - Irritation or redness of the eyes - Blurred vision or changes in near or distance vision - Eye pain - Stinging or burning of the eye - Twitching of the eyelids

Serious or Rare Side Effects: - Increased intraocular pressure - Inflammation of the eye - Corneal edema - Persistent bullous keratopathy - Retinal detachment or postoperative iritis following cataract extraction.

MIOSTAT should be used with caution in certain conditions. Precautions include:

- Cardiac conditions: Use with caution in patients with acute cardiac failure. - Respiratory conditions: Avoid in patients with bronchial asthma. - Gastrointestinal conditions: Use cautiously in patients with peptic ulcers or G.I. spasm. - Urinary conditions: Avoid in patients with urinary tract obstruction. - Neurological conditions: Use cautiously in patients with Parkinson's disease. - Allergies: The vial stopper contains natural rubber (latex), which may cause severe allergic reactions. - Storage: Store at 15° - 30°C (59° - 86°F): Keep in the original packaging, protect from moisture and light.

MIOSTAT may interact with other medications, leading to potential adverse effects. Major and moderate interactions include:

Major Interactions (Avoid): - Other cholinergic agents: May enhance the effects of carbachol, leading to excessive miosis or other cholinergic effects. - Anticholinergic agents: May reduce the effectiveness of carbachol.

Moderate Interactions (Monitor Closely): - Beta-blockers: May enhance the intraocular pressure-lowering effects of carbachol. - Carbonic anhydrase inhibitors: May enhance the intraocular pressure-lowering effects of carbachol. - Prostaglandin analogs: May enhance the intraocular pressure-lowering effects of carbachol.